Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genome Copying Errors02:46

Genome Copying Errors

5.0K
DNA replication is a well-evolved process that copies millions of base pairs with high fidelity during each cell division. Occasionally a wrong base or a long stretch of wrong bases may get added to the daughter strands. If the errors are left unchecked, cells might accumulate several mutations that might endanger their  survival. Therefore, the copying errors are checked and repaired at three levels.
5.0K
Mutations in Microorganisms01:18

Mutations in Microorganisms

479
Mutations are heritable changes in an organism’s genome involving alterations in the base sequence of DNA or RNA. These changes can influence cellular processes and phenotypic traits, potentially transforming the unaltered wild type into a mutant form. Such changes, termed forward mutations, are pivotal in shaping the genetic diversity of organisms.RNA viruses exhibit the highest mutation rates due to the absence of robust proofreading mechanisms during genome replication. In contrast,...
479
Mismatch Repair01:20

Mismatch Repair

6.2K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
6.2K
Mismatch Repair01:36

Mismatch Repair

43.5K
Overview
43.5K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Mutations01:39

Mutations

94.3K
Overview
94.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy, safety, and biomarker analysis of datopotamab deruxtecan in advanced non-small cell lung cancer: ICARUS-LUNG01 phase 2 study.

Cancer cell·2026
Same author

Psoriatic arthritis monocyte DNA methylomes bridge joint and skin inflammatory pathways across rheumatoid arthritis and psoriasis.

Annals of the rheumatic diseases·2026
Same author

fRagmentomics: an R package for integrating cell-free DNA fragment features with mutational status to support liquid biopsy interpretation.

Bioinformatics (Oxford, England)·2026
Same author

Candida albicans synergizes with Fusobacterium nucleatum in colorectal cancer progression via the Flo9-RadD interaction.

Cancer cell·2026
Same author

Utilisation of spatial methodologies for the investigation of the tumour microenvironment.

Methods in cell biology·2026
Same author

Author Correction: Microglial colonization of the developing mouse brain is controlled by both microglial and neural CSF-1.

The EMBO journal·2026
Same journal

Vascular RhoJ Is an Effective and Selective Target for Tumor Angiogenesis and Vascular Disruption.

Cancer cell·2026
Same journal

Intratumoral B cells under stress.

Cancer cell·2026
Same journal

Chronic stress unleashes an intratumor phage-fibroblast-B cell circuit to promote tumor growth.

Cancer cell·2026
Same journal

Molecular phenotypes and spatial archetypes: A new framework for cancer-associated fibroblasts.

Cancer cell·2026
Same journal

OpenIO: An open framework for AI-native immunotherapy.

Cancer cell·2026
Same journal

From prediction to interpretation in computational pathology.

Cancer cell·2026
See all related articles

Related Experiment Video

Updated: Jan 9, 2026

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

4.7K

When blood mutations turn beneficial.

Carlos de la Calle-Fabregat1, Elsa Bernard2, Florent Ginhoux1

  • 1Paris-Saclay University, Gustave Roussy, INSERM U1015, Villejuif, France.

Cancer Cell
|December 5, 2025
PubMed
Summary
This summary is machine-generated.

TET2-mutant clonal hematopoiesis (CH) in cancer patients can improve immunotherapy effectiveness. This occurs by enhancing macrophage antigen presentation and T cell activation, leading to better treatment outcomes.

More Related Videos

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells
11:06

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells

Published on: February 24, 2014

13.4K
Characterizing Mutational Load and Clonal Composition of Human Blood
07:58

Characterizing Mutational Load and Clonal Composition of Human Blood

Published on: July 11, 2019

7.8K

Related Experiment Videos

Last Updated: Jan 9, 2026

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

4.7K
Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells
11:06

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells

Published on: February 24, 2014

13.4K
Characterizing Mutational Load and Clonal Composition of Human Blood
07:58

Characterizing Mutational Load and Clonal Composition of Human Blood

Published on: July 11, 2019

7.8K

Area of Science:

  • Immunology
  • Oncology
  • Genetics

Background:

  • Clonal hematopoiesis (CH), characterized by expanded hematopoietic clones with somatic mutations, is prevalent in solid tumor patients.
  • CH is associated with adverse clinical outcomes in cancer.
  • The role of CH in response to cancer therapies remains incompletely understood.

Purpose of the Study:

  • To investigate the impact of TET2-mutant clonal hematopoiesis on the efficacy of cancer immunotherapy.
  • To elucidate the mechanisms by which CH influences the anti-tumor immune response.

Main Methods:

  • Analysis of patients with solid tumors and CH.
  • Immunohistochemical staining and flow cytometry to assess immune cell populations and function.
  • In vivo and in vitro assays to evaluate antigen presentation and T cell activation.

Main Results:

  • TET2-mutant CH was found to enhance macrophage antigen presentation.
  • This enhancement led to increased CD8+ T cell activation in the tumor microenvironment.
  • Improved antigen presentation and T cell activation correlated with better therapeutic efficacy of immunotherapy.

Conclusions:

  • TET2-mutant clonal hematopoiesis positively modulates the immune response to immunotherapy in cancer patients.
  • CH can enhance macrophage function, improving antigen presentation and T cell responses.
  • Targeting or understanding CH may offer new strategies to improve cancer immunotherapy outcomes.